每篇研究文章的透明度声明。
Declaration of transparency for each research article.
出版信息
BMJ. 2013 Aug 7;347:f4796. doi: 10.1136/bmj.f4796.
Abstract
An antidote to inadequate reporting of research
摘要
研究报告不充分的解毒剂
相似文献
1
Declaration of transparency for each research article.每篇研究文章的透明度声明。
BMJ. 2013 Aug 7;347:f4796. doi: 10.1136/bmj.f4796.
2
Conflict of interest, round 2.利益冲突，第二轮。
Am J Psychiatry. 2006 Sep;163(9):1481-3. doi: 10.1176/ajp.2006.163.9.1481.
3
Journals should set a new standard in transparency.期刊应在透明度方面树立新的标准。
Nature. 2007 Jan 25;445(7126):364. doi: 10.1038/445364a.
4
Competing interests.利益冲突。
Nat Biotechnol. 2003 Oct;21(10):1131. doi: 10.1038/nbt1003-1131a.
5
Financial associations of authors.作者的财务关联。
N Engl J Med. 2002 Jun 13;346(24):1901-2. doi: 10.1056/NEJMe020074.
6
Ghostbusters should only bust ghosts.捉鬼敢死队只应捉鬼。
Nat Biotechnol. 2008 Oct;26(10):1067-8. doi: 10.1038/nbt1008-1067.
7
Disclosure of conflicts of interest in biomedical publications.生物医学出版物中利益冲突的披露。
Can J Anaesth. 2008 May;55(5):265-7, 267-9. doi: 10.1007/BF03017202.
8
Nothing to see here.没什么可看的。
Nat Biotechnol. 2008 May;26(5):476. doi: 10.1038/nbt0508-476.
9
Medicine in small doses.小剂量用药。
ANZ J Surg. 2017 Jul;87(7-8):538. doi: 10.1111/ans.14109.
10
Declaration of conflicts of interest in scientific publications.
World J Biol Psychiatry. 2009;10(1):2-5. doi: 10.1080/15622970802685032.
引用本文的文献
1
The development of QERM scoring system for comprehensive assessment of the Quality of Empirical Research in Medicine - Part 1.QERM 评分系统的发展用于全面评估医学实证研究的质量 - 第 1 部分。
J Postgrad Med. 2022 Oct-Dec;68(4):221-230. doi: 10.4103/jpgm.jpgm_460_22.
2
Quality Output Checklist and Content Assessment (QuOCCA): a new tool for assessing research quality and reproducibility.质量产出检查表和内容评估（QuOCCA）：一种评估研究质量和可重复性的新工具。
BMJ Open. 2022 Sep 26;12(9):e060976. doi: 10.1136/bmjopen-2022-060976.
3
Transparency in the International Journal of Medical Students.《国际医学生杂志》的透明度
Int J Med Stud. 2014 Feb 28;2(1):6-7. doi: 10.5195/ijms.2014.67.
4
Effectiveness of integrated treatment for eating disorders in Spain: protocol for a multicentre, naturalistic, observational study.西班牙进食障碍综合治疗的效果：一项多中心、自然主义、观察性研究方案。
BMJ Open. 2021 Mar 8;11(3):e043152. doi: 10.1136/bmjopen-2020-043152.
5
Comparison of video and in-hospital consultations during early in-home care for premature infants and their families: A randomised trial.视频与院内咨询在早产儿及其家庭早期居家护理中的比较：一项随机试验。
J Telemed Telecare. 2022 Jan;28(1):24-36. doi: 10.1177/1357633X20913411. Epub 2020 Mar 30.
6
Transparency and reproducibility: A step forward.透明度与可重复性：向前迈进的一步。
Health Sci Rep. 2019 Mar 7;2(3):e117. doi: 10.1002/hsr2.117. eCollection 2019 Mar.
7
Reporting guidelines: doing better for readers.报告规范：为读者做得更好。
BMC Med. 2018 Dec 14;16(1):233. doi: 10.1186/s12916-018-1226-0.
8
Publishing descriptions of non-public clinical datasets: proposed guidance for researchers, repositories, editors and funding organisations.发布非公开临床数据集的描述：为研究人员、数据库、编辑和资助机构提供的拟议指南。
Res Integr Peer Rev. 2016 Jun 22;1:6. doi: 10.1186/s41073-016-0015-6. eCollection 2016.
9
Systematic review: Outcome reporting bias is a problem in high impact factor neurology journals.系统评价：结果报告偏倚是高影响因子神经学期刊中存在的一个问题。
PLoS One. 2017 Jul 20;12(7):e0180986. doi: 10.1371/journal.pone.0180986. eCollection 2017.
10
Guidance in author instructions of hematology and oncology journals: A cross sectional and longitudinal study.血液学和肿瘤学杂志作者指南：一项横断面和纵向研究。
PLoS One. 2017 Apr 28;12(4):e0176489. doi: 10.1371/journal.pone.0176489. eCollection 2017.
本文引用的文献
1
Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis.系统评价中随机对照试验结局的选择性报告：囊性纤维化篇
BMJ Open. 2013 Jun 20;3(6):e002709. doi: 10.1136/bmjopen-2013-002709.
2
Comparison of randomized controlled trial registry entries and content of reports in surgery journals.随机对照试验注册库条目与外科期刊报告内容的比较。
Ann Surg. 2013 Jun;257(6):1007-15. doi: 10.1097/SLA.0b013e318283cf7f.
3
Overinterpretation and misreporting of diagnostic accuracy studies: evidence of "spin".过度解读和错误报告诊断准确性研究：“炒作”的证据。
Radiology. 2013 May;267(2):581-8. doi: 10.1148/radiol.12120527. Epub 2013 Jan 29.
4
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.乳腺癌女性随机临床试验中疗效和毒性终点报告的偏倚。
Ann Oncol. 2013 May;24(5):1238-44. doi: 10.1093/annonc/mds636. Epub 2013 Jan 9.
5
Industry sponsorship and research outcome.行业赞助与研究成果。
Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033. doi: 10.1002/14651858.MR000033.pub2.
6
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准（CONSORT）以及医学期刊上发表的随机对照试验（RCT）的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
7
Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: a systematic review.前瞻性注册和结局报告偏倚对湿疹治疗随机对照试验的影响：系统综述。
J Invest Dermatol. 2012 Dec;132(12):2727-34. doi: 10.1038/jid.2012.231. Epub 2012 Jul 26.
8
Quality of reporting of modern randomized controlled trials in medical oncology: a systematic review.现代肿瘤医学随机对照试验报告质量的系统评价。
J Natl Cancer Inst. 2012 Jul 3;104(13):982-9. doi: 10.1093/jnci/djs259.
9
The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates.研究抗 CCP 抗体在类风湿关节炎中的诊断准确性及其对诊断估计影响的研究报告质量。
BMC Musculoskelet Disord. 2012 Jun 25;13:113. doi: 10.1186/1471-2474-13-113.
10
The reporting of harms in randomized controlled trials of hypertension using the CONSORT criteria for harm reporting.使用 CONSORT 伤害报告标准报告高血压随机对照试验中的伤害。
Clin Exp Hypertens. 2012;34(8):548-54. doi: 10.3109/10641963.2012.681724. Epub 2012 May 9.
Zotero 插件